Research suggests that Triphala's three constituent fruits — amla, bibhitaki, and haritaki — contribute complementary phytochemical profiles that may support detoxification-related biological processes, with one 2025 in vitro study finding that combining all three extracts produced a synergistic activation of the body's endogenous antioxidant and detoxification pathways, an effect stronger than any single fruit extract alone. A 2024 metabolomics study using mass spectrometry identified over 2,500 annotated metabolites across the three fruits, including 71 polyphenols predicted to interact with gut microbiota and human targets related to antioxidant activity, offering a molecular-level rationale for why the traditional combination has been valued. The available evidence consists entirely of laboratory and analytical studies rather than clinical trials in humans, so while these findings are mechanistically suggestive, they do not yet establish whether Triphala produces meaningful detoxification effects in living people. A separate 2017 study also raised quality control concerns, finding that standard DNA barcoding methods often fail to reliably authenticate Terminalia species, which means the botanical identity of commercially sold Triphala ingredients is not always verifiable — a limitation worth considering when evaluating any research or product in this area.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Myrobalan Fruit Extracts Modulate Immunobiochemical Pathways In Vitro. | Other | 2025 | Supports | 100 |
| A comprehensive metabolome profiling of Terminalia chebula, Terminalia beller... | Other | 2024 | Supports | 95 |
| Evaluation of single and multilocus DNA barcodes towards species delineation ... | Other | 2017 | Neutral | 90 |